Newsstand Menu

Home / Newsstand / CSHL Stories and Media

CSHL Stories and Media archive for Tag: David Tuveson

Filter by tag

Image of mouse pancreas cells with SRSF1 protein

This killer protein causes pancreatic cancer

4/26/2023

CSHL researchers have found that high levels of a protein called SRSF1 can cause pancreatitis and jumpstart tumor development. Read the story »

Image of Clarivate Highly Cited Researchers 2022

CSHL professors on the cutting edge of scientific research

11/21/2022

Four CSHL researchers were ranked among the world’s most cited in 2022. Read the story »

David Tuveson wins 2022 Luminary Award

11/17/2022

The award, presented on World Pancreatic Cancer Day, honors Tuveson for his efforts to find a cure and improve patients’ lives. Read the story »

Illustration of archer hitting bullseye on human foot

Targeting cancer’s Achilles heel

11/4/2022

Biden’s Cancer Moonshot aims to cut annual deaths in half. CSHL scientists have the goal in their sights. Read the story »

David Tuveson elected to National Academy of Medicine

10/17/2022

Tuveson was recognized for his pioneering cancer organoid research that led to the development of the first mouse models for pancreatic cancer. Read the story »

How organoids can guide pancreatic cancer therapy

7/20/2022

CSHL researchers have found mini-versions of patient tumors, called organoids, can help optimize chemotherapy before tumor-removal surgery. Read the story »

image of the Harbor Transcript cover Winter 2021 edition

Lab meets clinic: Building on foundational research

12/15/2021

The future depends on investments in scientific advancement, including expanding the Laboratory’s research visions and shoring up its infrastructure. Read the story »

photo of postdocs working in Nick Tonks lab

CSHL receives 2021 NCI grant of $4.5 million

10/1/2021

The National Cancer Institute renewed its Basic Laboratory Cancer Center grant for CSHL, marking 34 years of our continued progress in cancer research. Read the story »

Mestag, co-founded by CSHL prof, named leading new biotech

9/27/2021

Fierce Biotech named Mestag Therapeutics, co-founded by CSHL Professor David Tuveson, a 2021 “Fierce 15” leader in the biotech and pharma business. Read the story »

photo of Camila dos Santos and Mary Sabulski

CSHL organoid facility: Cancer custodians

7/2/2021

To beat our worst enemy, we must first let it grow. Read the story »

How pancreatic cancer cells dodge drug treatments

6/22/2021

CSHL scientists discovered a new clue that might explain how some pancreatic cancers evade cancer-killing drugs. Read the story »

image of the Harbor Transcript Summer 2021 edition

Research matters

6/8/2021

Innovative research and educational activities never stopped during the COVID-19 pandemic. Read the story »

$11 million investment to develop fibroblast therapeutic

4/26/2021

CSHL Professor David Tuveson and other leading disease experts founded a company to target fibroblasts as a new way to treat cancer and inflammatory diseases. Read the story »

Dr. David Tuveson inaugurated as AACR president

4/21/2021

CSHL Cancer Center Director David Tuveson is leading the American Association for Cancer Research. Read the story »

photo of Dennis Plenker working at the organoid facility

CSHL’s new organoid facility

11/5/2020

The 2,200 square foot facility will make and maintain hundreds of live tissue models grown from patient tumors. Read the story »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.